Grand Challenges: Accelerating Innovations to Address Heavy Menstrual Bleeding in Women in Low-Resource Settings
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- _ You can learn more about this opportunity by visiting the funder's [website](https://gcgh.grandchallenges.org/sites/default/files/files/heavy_menstrual_bleeding_rfp.pdf).
Overview
Background
Heavy menstrual bleeding (HMB) affects millions of women globally. Clinically, HMB is defined as excessive menstrual blood loss that negatively affects a woman's physical, emotional, and social well-being. In research settings, HMB is defined as directly measured blood loss exceeding 80 milliliters per menstrual cycle. Many women seek medical attention based on their perceptions of heavy bleeding and its impact on daily life. Abnormal uterine bleeding, of which HMB is a subset, is caused by various factors. Structural abnormalities include polyps, adenomyosis, fibroids, and malignancy, while non-structural factors include bleeding disorders, ovulatory and endometrial dysfunction, and other factors.
The Challenge
We invite research proposals on HMB based on the clinical definition that focus on:
- Biological Mechanisms – Advancing understanding of the fundamental biology of HMB to identify targets for innovative diagnostics and treatments.
- Epidemiology and Impact – Assessing disease burden, patterns, and impact on gynecological health and quality of life in women in low-resource settings.
- Measurement and Standardization – Developing and validating improved methods for measuring HMB and establishing standardized research protocols to enable consistent and comparable studies across diverse populations and healthcare systems.
- Innovative Diagnostics – Proposing new technology or piloting the use of existing technology to identify causes of HMB in low resource settings, including the use of artificial intelligence. Technology should be easy to use and affordable.
- Treatment and Access – Evaluating the effectiveness, acceptability, and ways to increase access to treatment including hormonal contraceptives, to inform patient-centered care in low-resource settings.
Please see FAQs for additional guidelines.
Eligibility
_ You can learn more about this opportunity by visiting the funder's website.
What Gates Foundation actually gave
Source: IRS Form 990-PF, 2024
- Grants in 2024
- 4,974
- Total given
- $6.31B
- 25% of recipients were new grantees, not repeat recipients.
Focus Areas & Funding Uses
Fields of Work
- Science research
- Reproductive health
- Women
- Global health
- Health disparities
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing: Option B Grant
Gates Foundation
Amount
Varies
Deadline
Deadline not published
The Gates Scholarship (TGS) Grant
Gates Foundation
Amount
Varies
Deadline
Deadline not published
Accelerating Innovation in Vaginal Formulations in Support of Women's Health Grant
Gates Foundation
Amount
Up to US $250,000
Deadline
Deadline not published
Grand Challenges: Reducing the Burden of Preeclampsia
Gates Foundation
Amount
Varies
Deadline
Deadline not published
Grand Challenges: Innovations for Gram-Negative Antibiotic Discovery
Gates Foundation
Amount
Varies
Deadline
Deadline not published
Grand Challenges: Enhancing HIV and TB Diagnosis: Adjunct Technologies for Sample Collection and Processing
Gates Foundation
Amount
Varies
Deadline
Deadline not published
Ready to apply for Grand Challenges: Accelerating Innovations to Address Heavy Menstrual Bleeding in Women in Low-Resource Settings?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Grand Challenges: Accelerating Innovations to Address Heavy Menstrual Bleeding in Women in Low-Resource Settings. Now let's win it.